What Does Mild, Moderate, or Severe IBD Actually Mean?

When a gastroenterologist calls your inflammatory bowel disease mild, moderate, or severe, that single word stands in for a much larger picture. Inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, is a chronic condition in which abnormal reactions of the immune system cause inflammation in the digestive tract, according to the National Institute of Diabetes and Digestive and Kidney Diseases. The severity label is not a fixed grade stamped on you once. It is assembled from several measurable factors: your symptoms, blood and stool tests, what the lining of your bowel looks like during endoscopy, imaging, complications, and how much the disease disrupts your daily life. Understanding what feeds into that word helps you read your own results and have a more useful conversation at each visit.

What severity is actually measuring

Part of the confusion around the question of what moderate IBD means is that clinicians use two related ideas. Disease activity describes how much inflammation is present right now, while severity describes the broader burden of the disease over time, including its course and its effect on your life. The 2025 American College of Gastroenterology guideline for ulcerative colitis frames severity across four components: patient-reported outcomes such as bleeding and urgency, inflammatory burden measured by endoscopy and laboratory markers, disease course such as prior hospitalizations or steroid use, and disease impact on quality of life and social functioning. Seen this way, a label is a summary of many trackable pieces rather than one number, which is why two people with the same stool frequency can end up in different categories.

How ulcerative colitis severity is graded

For ulcerative colitis, one of the oldest and still widely used systems is the Truelove and Witts classification, first published in the 1950s. Under these criteria, a severe attack is defined by six or more bloody stools per day plus at least one systemic sign: a temperature above 37.8 degrees Celsius, a pulse over 90 beats per minute, hemoglobin below 105 grams per liter, or an erythrocyte sedimentation rate above 30 millimeters per hour, as described in a prospective study of the Truelove and Witts criteria. Mild disease sits at the other end, with fewer stools, little visible blood, and no systemic upset. What you see on the inside matters too. The ACG guideline recommends grading the appearance of the colon lining using the Mayo Endoscopic Score or the Ulcerative Colitis Endoscopic Index of Severity, and it treats resolution of inflammatory changes, meaning a Mayo endoscopic score of 0 or 1, as a treatment target. Extent counts as well, since the NIDDK notes that endoscopy is used to find out how severe ulcerative colitis is and how much of the large intestine is affected.

How Crohn's disease severity is measured

Crohn's disease is harder to capture with a single stool count because it can develop anywhere in the digestive tract from the mouth to the anus, as the NIDDK explains. The most established research tool is the Crohn's Disease Activity Index, a composite of symptoms, well-being, and laboratory findings. A reference summary of Crohn's outcome measures reports that a score of 150 marks the threshold between remission and active disease, scores between 150 and 219 indicate mild to moderate disease, scores between 220 and 450 indicate moderate to severe disease, and scores above 450 indicate very severe disease. Because symptoms alone can mislead, guidelines increasingly lean on objective markers of inflammation. The AGA guideline on biomarkers for Crohn's disease suggests that a fecal calprotectin above 150 micrograms per gram or a C-reactive protein above 5 milligrams per liter points toward active inflammation and may prompt a change in treatment, while lower values support quieter disease. This is why your Crohn's label may weigh a normal-feeling week against an abnormal calprotectin result.

The factors behind the label

Rather than one measurement, a severity label reflects a bundle of factors your care team weighs together. Tracking them individually turns a vague word into something you can see and discuss.

Severity factor	What it reflects
Symptoms	Stool frequency, rectal bleeding, urgency, and abdominal pain reported by you
Blood and stool tests	Inflammation and complications, such as anemia, C-reactive protein, and fecal calprotectin
Endoscopy and imaging	Depth and extent of inflammation, ulcers, and structural damage inside the bowel
Complications and daily impact	Hospitalizations, steroid use, and how much the disease limits work and social life

The Crohn's & Colitis Foundation describes how symptoms differ by where disease is located, which is another reason the same label can look different from one person to the next. Blood tests, stool tests, and endoscopy together let a clinician confirm the diagnosis and judge both how active and how extensive the inflammation is, as the NIDDK outlines.

Why your severity label can change

Both Crohn's disease and ulcerative colitis are chronic conditions that fluctuate between periods of active symptoms, called flares, and symptom-free periods, called remission, according to the NIDDK. Because of that rhythm, the category you were given at diagnosis is a snapshot in time. A person labeled severe during an acute attack may be graded mild once treatment brings the inflammation down, and someone told they had mild disease can move into a higher category if a flare or a rising calprotectin signals more inflammation. This is the practical value of understanding what mild, moderate, and severe mean. The words describe a moving set of measurements, so keeping a record of your symptoms, lab values, endoscopy results, and daily impact over time gives you and your care team the full picture behind whichever label appears in your chart today.